Daily Subjective and Objective Smartphone Measures of Illness Activity to Treat Bipolar Disorder- The MONARCA II Trial (MONARCAII)

April 5, 2018 updated by: Maria Faurholt-Jepsen, Psychiatric Centre Rigshospitalet

Daily Electronic Monitoring of Subjective and Objective Measures of Illness Activity in Bipolar Disorder - The MONARCA II Trial (MONitoring, treAtment and pRediCtion of bipolAr Disorder Episodes II)

Bipolar disorder is associated with a high risk of relapse and hospitalisation and many patients do not recover to their previous psychosocial function. Major reasons for poor outcomes are delayed intervention for prodromal depressive and manic symptoms as well as decreased adherence with treatment.

Recently, in the MONARCA I trial (NCT01446406), the investigators developed and deployed a smartphone based self-monitoring system (the MONARCA I system) in a randomized controlled trial, to test the effect of daily reporting of subjective self-monitoring of depressive and manic symptoms as well as a bi-directional feedback loop on depressive and manic symptoms.

In the MONARCA II trial the investigators will develop and deploy a new version of the smartphone based monitoring system. The investigators will in a randomized controlled single blind trial investigate whether daily electronic monitoring of subjective and objective measures of illness activity using a smartphone based self-monitoring system including feedback on subjective as well as automatically generated objective data (e.g.social activity, physical activity etc.) (the MONARCA II system) reduces the severity of depressive and manic symptoms and improves functioning more than a control group receiving a smartphone. All patients will be followed for 9 months with outcome assessments at baseline, after 4 weeks, after 3 months, after 6 months and after 9 months.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

146

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2100
        • Psychiatric Centre Copenhagen, Rigshospitalet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Bipolar Disorder according to SCAN interview
  • ≥18 years of age
  • Patients who previously have received a course of treatment at the Clinic for Affective Disorders, Psychiatric Centre Copenhagen, Denmark

Exclusion Criteria:

  • Pregnancy
  • Lack of Danish language skills
  • Patients who previously have received and used the MONARCA I system for self-monitoring

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Non-MONARCA II system
Use of smartphone for normal communicative purposes only. No self-monitoring and no feedback loop.
Daily use of smartphone for normal communicative purposes. No self-monitoring in the MONARCA II system.
Experimental: The MONARCA II system
Daily electronic monitoring of subjective and objective smartphone measures including a feedback loop
Daily electronic monitoring of subjective and objective smartphone measures including a feedback loop
Other Names:
  • Non-MONARCA II system (control group condition)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences between the groups in depressive and manic symptoms and the number of affective episodes
Time Frame: Baseline and up to 9 months
Differences between the groups in depressive and manic symptoms measured using Hamilton Depression Rating Scale (HDRS) and Young Mania Rating Scale (YMRS) and episodes defined ad HDRS<= 14 and/or YMRS<= 14
Baseline and up to 9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences between the groups in smartphone measures
Time Frame: Baseline and up to 9 months

Differences between the groups in:

-Automatically generated objective smartphone measures

Baseline and up to 9 months
Differences between the groups in number of hospitalizations
Time Frame: Baseline up to 9 months follow up
Differences between the groups in number of hospitalization
Baseline up to 9 months follow up
Differences between the groups in number of contacts to clinicians and emergency rooms
Time Frame: Baseline up to 9 months follow up
Differences between the groups in number of contacts to clinicians and emergency rooms
Baseline up to 9 months follow up
Differences between the groups in functioning
Time Frame: Baseline up to 9 months follow up
Differences between the groups in functioning measured using the FAST questionnaire
Baseline up to 9 months follow up
Differences between the groups in perceived stress
Time Frame: Baseline up to 9 months
Differences between the groups in perceived stress using the perceived stress questionnaire
Baseline up to 9 months
Differences between the groups in quality of life
Time Frame: Baseline up to 9 months follow up
Differences between the groups in quality of life measured using the WHOQoL questionnaire
Baseline up to 9 months follow up
Differences between the groups in self-rated depressive symptoms
Time Frame: Baseline up to 9 months
Differences between the groups in self-rated depresisve symptoms using the BDI questionnaire
Baseline up to 9 months
Differences in self-rated manic symptoms
Time Frame: Baseline up to 9 months follow up
Differences between the groups in self-rated manic symptoms using the ASRM questionnaire
Baseline up to 9 months follow up
Differences between the groups in adherence to medication
Time Frame: Baseline up to 9 months follow up
Differences between the groups in adherence to medication measured using the questionnaire MARS
Baseline up to 9 months follow up
Differences between the groups in recovery
Time Frame: Baseline up to 9 months follow up
Differences between the groups in recovery using the questionnaire Recovery Assessment Scale (RAS)
Baseline up to 9 months follow up
Differences between the groups in empowerment
Time Frame: baseline up ot 9 months
Differences between the groups in empowerment using the questionnaire Rogers Empowerment scale.
baseline up ot 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Faurholt-Jepsen, MD, Psychiatric Centre Copenhagen, Rigshospitalet, Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

January 1, 2018

Study Completion (Actual)

January 1, 2018

Study Registration Dates

First Submitted

August 12, 2014

First Submitted That Met QC Criteria

August 18, 2014

First Posted (Estimate)

August 20, 2014

Study Record Updates

Last Update Posted (Actual)

April 6, 2018

Last Update Submitted That Met QC Criteria

April 5, 2018

Last Verified

April 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bipolar Disorder

Clinical Trials on Non-MONARCA II system

Subscribe